.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,952,466

« Back to Dashboard

Details for Patent: 5,952,466

Title: Reductive alkylation of glycopeptide antibiotics
Abstract:This invention is concerned with improved processes for reductive alkylation of glycopeptide antibiotics. The improvement residing in providing a source of copper which results in the initial production of a copper complex of the glycopeptide antibiotic. Reductive alkylation of this complex favors regioselective alkylation and increased yields. Copper complexes of the glycopeptide antibiotic starting materials and of the alkylated products are also part of the invention.
Inventor(s): Berglund; Richard Alan (Lafayette, IN), Lockwood; Nancy Anne (Mountlake Terrace, WA), Magadanz; Howard Eugene (Lafayette, IN), Zheng; Hua (Lafayette, IN)
Assignee: Eli Lilly and Company (Indianpolis, ID)
Filing Date:Nov 12, 1997
Application Number:08/968,968
Claims:1. A method for reductively alkylating a glycopeptide antibiotic comprising an amine-containing saccharide at N.sup.4 and one or more other amines, which comprises reacting a soluble copper complex of the glycopeptide antibiotic with a ketone or aldehyde in the presence of a reducing agent which is sodium cyanoborohydride or pyridine.cndot.borane complex.

2. A method of claim 1 which is conducted in methanol.

3. A method of claim 2 in which the soluble copper complex of the glycopeptide antibiotic is prepared in situ from the glycopeptide antibiotic and a soluble form of copper.

4. A method of claim 3 wherein the glycopeptide antibiotic is a vancomycin type glycopeptide antibiotic.

5. A method of claim 4 wherein the glycopeptide antibiotic is A82846B.

6. A method of claim 5 wherein the aldehyde is 4'-chloro-4-biphenylcarboxaldehyde.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc